MedlineR: an open source library in R for Medline literature data mining.

PubWeight™: 1.29‹?› | Rank: Top 10%

🔗 View Article (PMID 15284107)

Published in Bioinformatics on July 29, 2004

Authors

Simon M Lin1, Patrick McConnell, Kimberly F Johnson, Jennifer Shoemaker

Author Affiliations

1: Duke Comprehensive Cancer Center, Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC 27710, USA. Lin00025@mc.duke.edu <Lin00025@mc.duke.edu>

Articles by these authors

An anatomy of normal and malignant gene expression. Proc Natl Acad Sci U S A (2002) 4.45

Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition. Nat Struct Mol Biol (2004) 4.40

Statistical issues with microarrays: processing and analysis. Trends Genet (2002) 2.60

A molecular neuroethological approach for identifying and characterizing a cascade of behaviorally regulated genes. Proc Natl Acad Sci U S A (2006) 2.02

A single-center strategy to minimize blood transfusion in neonates and children undergoing cardiac surgery. Paediatr Anaesth (2015) 2.01

A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression. J Clin Invest (2004) 1.48

Discovery and characterization of a novel inhibitor of matrix metalloprotease-13 that reduces cartilage damage in vivo without joint fibroplasia side effects. J Biol Chem (2007) 1.37

Multiple sclerosis immunology: The healthy immune system vs the MS immune system. Neurology (2010) 1.34

Diagnosis of suspicious thyroid nodules using four protein biomarkers. Clin Cancer Res (2006) 1.07

Factors that influence adherence and strategies to maintain adherence to injected therapies for patients with multiple sclerosis. J Neurosci Nurs (2010) 1.06

Binding thermodynamics of substituted diaminopyrimidine renin inhibitors. Anal Biochem (2006) 1.04

Molecular profiling of matched samples identifies biomarkers of papillary thyroid carcinoma lymph node metastasis. Cancer Res (2007) 0.91

Emerging multiple sclerosis oral therapies. Neurology (2010) 0.90

Injectable disease-modifying therapy for relapsing-remitting multiple sclerosis: a review of adherence data. J Neurosci Nurs (2010) 0.89

Rational protein engineering in action: the first crystal structure of a phenylalanine tRNA synthetase from Staphylococcus haemolyticus. J Struct Biol (2007) 0.81

Effects of modifications of the linker in a series of phenylpropanoic acid derivatives: Synthesis, evaluation as PPARalpha/gamma dual agonists, and X-ray crystallographic studies. Bioorg Med Chem (2008) 0.81

Discovery of a series of 2-(1H-pyrazol-1-yl)pyridines as ALK5 inhibitors with potential utility in the prevention of dermal scarring. Bioorg Med Chem Lett (2012) 0.80

The design and synthesis of human branched-chain amino acid aminotransferase inhibitors for treatment of neurodegenerative diseases. Bioorg Med Chem Lett (2005) 0.77

Synthesis and evaluation of novel alpha-heteroaryl-phenylpropanoic acid derivatives as PPARalpha/gamma dual agonists. Bioorg Med Chem (2009) 0.77

Highly selective 2,4-diaminopyrimidine-5-carboxamide inhibitors of Sky kinase. Bioorg Med Chem Lett (2012) 0.75

Subclavian vein aneurysm secondary to a benign vessel wall hamartoma. Pediatr Radiol (2013) 0.75

Qualitative Analysis of Health Coaches' Experiences during a Workplace Wellness Intervention: 2121 Board #273 June 2, 3: 30 PM - 5: 00 PM. Med Sci Sports Exerc (2016) 0.75